Dipal Doshi Joins Azenta's Board of Directors as a Strategic Move Dipal Doshi, CEO of Entrada Therapeutics, has been elected to Azenta's Board of Directors, signaling a strategic enhancement for the firm.

Dipal Doshi Joins Azenta's Board of Directors as a Strategic Move #USA #Burlington #Azenta #Dipal_Doshi #Entrada_Therapeutics